Atlas Trials

Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer

Clinical trial NCT00004202 · COMPLETED

Trial details

NCT number
NCT00004202
Sponsor
Spectrum Pharmaceuticals, Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
1998-10-01
Primary completion
2003-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.